DRDO-developed anti-Covid 19 drug gets DCGI approval for emergency use

0 29

An anti-COVID oral drug developed by the DRDO has been approved by the Drugs Controller General of India (DCGI) for emergency use as an adjunct therapy in moderate to severe coronavirus patients, the defence ministry said on Saturday.

Leave A Reply

Your email address will not be published.